Stock GBLX GB SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News GB Sciences, Inc.

Equities

GBLX

US3615441090

Delayed OTC Markets
Other stock markets
 14:30:18 24/05/2024 BST 		5-day change 1st Jan Change
0.012 USD -0.83% Intraday chart for GB Sciences, Inc. +26.32% +87.50%
02-12 GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
GB Sciences, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
GB Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
GB Sciences, Inc. Auditor Raises 'Going Concern' Doubt
CI
Gb Sciences' First-In-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study At the University of Lethbridge
CI
GB Sciences, Inc. announced a financing transaction
CI
GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
GB Sciences, Inc. Announces Executive Changes
CI
GB SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
GL
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
AQ
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GBLX Stock
  4. News GB Sciences, Inc.